P-513 Improving pulmonary function in patients with malignant pleural mesothelioma: Results of the phase III trial of pemetrexed + cisplatin vs. cisplatin

Lung Cancer ◽

10.1016/s0169-5002(03)92480-9 ◽

2003 ◽

Vol 41 ◽

pp. S220 ◽

Author(s):

M. Pistolesi ◽

J. Symanowski ◽

U. Gatzemeier ◽

S. Emri ◽

P. Conte ◽

...

Keyword(s):

Pulmonary Function ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial

Download Full-text

183: PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

Lung Cancer ◽

10.1016/s0169-5002(15)50177-3 ◽

2015 ◽

Vol 87 ◽

pp. S68

Author(s):

N. Bayman ◽

D. Ardron ◽

L. Ashcroft ◽

D.R. Baldwin ◽

R. Booton ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

Prophylactic Irradiation

Download Full-text

P-514 Can baseline quality of life parameters predict survival and other efficacy outcomes in malignant pleural mesothelioma?: Results from a 448-patient phase III trial

Lung Cancer ◽

10.1016/s0169-5002(03)92481-0 ◽

2003 ◽

Vol 41 ◽

pp. S220 ◽

Author(s):

R.J. Gralla ◽

J.T. Symanowski ◽

A.M. Liepa ◽

M.J. Boyer ◽

P. Ruffie ◽

...

Keyword(s):

Quality Of Life ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial

Download Full-text

MesoTRAP: A feasibility study comparing video-assisted thoracoscopic partial pleurectomy/decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial

Lung Cancer ◽

10.1016/s0169-5002(18)30225-3 ◽

2018 ◽

Vol 115 ◽

pp. S89

Author(s):

R.C. Rintoul ◽

N. Maskell ◽

J.G. Edwards ◽

A.M. Tod ◽

L. Sharples ◽

...

Keyword(s):

Sample Size ◽

Feasibility Study ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

Indwelling Pleural Catheter ◽

Pleural Catheter ◽

Trapped Lung ◽

Partial Pleurectomy

Download Full-text

69 PIT: A phase III trial of prophylactic irradiation of tracks in patients with malignant pleural mesothelioma following invasive chest wall intervention

Lung Cancer ◽

10.1016/s0169-5002(12)70070-3 ◽

2012 ◽

Vol 75 ◽

pp. S23

Author(s):

N. Bayman ◽

L. Ashcroft ◽

S. Falk ◽

N. Stones ◽

D. Ardron ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

Prophylactic Irradiation

Download Full-text

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-2860 ◽

2019 ◽

Vol 25 (19) ◽

pp. 5759-5765 ◽

Author(s):

Guillaume Eberst ◽

Amélie Anota ◽

Arnaud Scherpereel ◽

Julien Mazieres ◽

Jacques Margery ◽

...

Keyword(s):

Quality Of Life ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Health Related Quality ◽

Phase Iii Trial ◽

Life Impact ◽

Related Quality ◽

Download Full-text

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Annals of Oncology ◽

10.1016/j.annonc.2020.09.009 ◽

2020 ◽

Vol 31 (12) ◽

pp. 1734-1745

Author(s):

S. Popat ◽

A. Curioni-Fontecedro ◽

U. Dafni ◽

R. Shah ◽

M. O'Brien ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Single Agent ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

Single Agent Chemotherapy

Download Full-text

Treatment-free interval (TFI) after first-line therapy as a prognostic and predictive factor in malignant pleural mesothelioma (MPM): Findings from the NGR015 phase III trial with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.7557 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 7557-7557

Author(s):

Vanesa Gregorc ◽

Domenico Ghio ◽

Claudio Sallemi ◽

Alessandra Bulotta ◽

Gilda Rossoni ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Predictive Factor ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

First Line Therapy ◽

Free Interval ◽

Download Full-text

Phase III trial (NGR015) with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC in previously treated patients with advanced malignant pleural mesothelioma (MPM).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.7501 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 7501-7501 ◽

Author(s):

Rabab M. Gaafar ◽

Adolfo G. Favaretto ◽

Vanesa Gregorc ◽

Francesco Grossi ◽

Jacek Jassem ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

Impact on health-related quality of life of the addition of bevacizumab to cisplatin-pemetrexed in malignant pleural mesothelioma in the MAPS phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.8505 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 8505-8505 ◽

Author(s):

Virginie Westeel ◽

Guillaume Eberst ◽

Amelie Anota ◽

Arnaud Scherpereel ◽

Julien Mazieres ◽

...

Keyword(s):

Quality Of Life ◽

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Download Full-text

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

BMJ Open ◽

10.1136/bmjopen-2015-010589 ◽

2016 ◽

Vol 6 (1) ◽

pp. e010589 ◽

Author(s):

N Bayman ◽

D Ardron ◽

L Ashcroft ◽

D R Baldwin ◽

R Booton ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Phase Iii ◽

Pleural Mesothelioma ◽

Phase Iii Trial ◽

Prophylactic Irradiation

Download Full-text